跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LAMICTAL lamotrigine 5 mg dispersible/chewable tablet bottle - TGA Drug Approval Details
Approvals
/
TGA
/
LAMICTAL lamotrigine 5 mg dispersible/chewable tablet bottle
Approved
STANDARD
LAMICTAL lamotrigine 5 mg dispersible/chewable tablet bottle
Aspen Pharmacare Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
c2dbea68c684d6e8
Company
Aspen Pharmacare Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
c2dbea68c684d6e8
Product Name
LAMICTAL lamotrigine 5 mg dispersible/chewable tablet bottle
Artg Id
51718
Artg Name
LAMICTAL lamotrigine 5 mg dispersible/chewable tablet bottle
Sponsor
Aspen Pharmacare Australia Pty Ltd
Company Detail Path
/organization/aspen-pharmacare-australia-pty-ltd
Artg Date
1995-04-26
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/fc2bc078f8200696fb670ad93261a772.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/4d9052abacd15e81f2d22070971f5ba0.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
c2dbea68c684d6e8
Type
Standard
Back to TGA Approvals